Navigation Links
New Analysis Assesses Impact of Common Genetic Variation on Benefit of Antiplatelet Therapy
Date:3/15/2010

dogrel.

Study Methodology

TRITON-TIMI 38 was a Phase III, randomized, double-blind, head-to-head clinical trial comparing the effects of Effient versus clopidogrel in patients with ACS who were managed with PCI, a procedure to open blockages in heart arteries, including the use of coronary stenting. The study enrolled 13,608 patients at 707 trial sites in 30 countries.

The primary endpoint of the study was the combined incidence of cardiovascular death, non-fatal heart attack or non-fatal stroke during a median period of at least 12 months following PCI. Patients were randomly assigned to one of two treatment groups and given a loading dose of either Effient 60 mg or the FDA-approved loading dose of clopidogrel 300 mg, followed by a daily maintenance dose of either Effient 10 mg or clopidogrel 75 mg. All patients also received a daily dose of aspirin (75 mg to 325 mg).

This analysis was designed to examine whether specific genetic variations could affect patient response to antiplatelet therapy. The pharmacogenetic analyses examined DNA samples from 2,943 patients from the TRITON-TIMI 38 clinical trial.


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... NAGOYA, Japan , Aug. 19, 2014 ... ASAHI INTECC (Securities Code 7747, Second Section, ... plans to develop a new, differentiated fractional flow reserve ... device intended to improve handling compared to existing FFR ... field in interventional cardiology that exceeds $250 million worldwide ...
(Date:8/18/2014)... Gamida Cell , a world leader ... that it has signed an investment and option agreement with ... " ) . According to the agreement, Novartis ... will receive 15% equity and an option to fully acquire ... of time following achievement of certain milestones connected to the ...
(Date:8/18/2014)... 2014 Reportlinker.com announces that a new ... Global Operating Room Equipment Market ... About Operating Room Equipment ... a sterile environment in a healthcare facility used ... technically advanced equipment, which ensures patient care and ...
Breaking Medicine Technology:Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 2Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 3Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 4Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company 2Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company 3Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company 4Global Operating Room Equipment Market 2014-2018 2Global Operating Room Equipment Market 2014-2018 3Global Operating Room Equipment Market 2014-2018 4Global Operating Room Equipment Market 2014-2018 5Global Operating Room Equipment Market 2014-2018 6
... Cumberland Pharmaceuticals Inc. (Nasdaq: ... an exclusive agreement with China,s Harbin Gloria Pharmaceuticals ... ( acetylcysteine ), its injectable drug used to treat ... is used to treat pain and fever in the ...
... Ore., Feb. 28, 2012 For the first ... psoriasis—a disease of the immune system that appears ... million Americans—and psoriatic arthritis—an inflammatory joint and tendon ... Recognition on items that dermatology experts deem effective ...
Cached Medicine Technology:Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement for China 2Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement for China 3Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement for China 4Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement for China 5National Psoriasis Foundation Launches "Seal of Recognition" for Psoriasis Products 2National Psoriasis Foundation Launches "Seal of Recognition" for Psoriasis Products 3
(Date:8/19/2014)... The elegant bamboo floorings from BambooIndustry.com are ... in an environmentally conscious way with the company’s floorings. ... have an aluminum oxide finish to help resist wear ... areas. , Recently, the company has released its new ... These fresh items are specially made for global customers. ...
(Date:8/19/2014)... As moms and dads prepare their children ... to the normal routine of dropping their little ones off ... MSc, RD encourages them to use the opportunity to ... , Yarker explains, “Kids have small tummies, short attention ... them junk food handouts, use snack time as another daily ...
(Date:8/19/2014)... 2014 BambooIndustry.com, a well-known bamboo product manufacturer ... deckings recently. The company is excited to reveal the ... special offer for all clients. Now, every customer can get ... will last until August 30. , The company’s deckings ... the world for supreme durability. They are perfect for a ...
(Date:8/19/2014)... Dentistry in Houston, Texas, is pleased to announce it is ... or with old fillings that need replacing, will benefit from ... restore teeth. , From now on any cavities will be ... completely amalgam free. Even though amalgam fillings have been deemed ... and children over the age of six, they do contain ...
(Date:8/19/2014)... Il (PRWEB) August 20, 2014 For ... allopathic medical world that chiropractic adjustments are dangerous and ... and this is why they do not recommend chiropractic ... more educated medical doctors do refer to chiropractors because ... However a statement regarding new research has popped up ...
Breaking Medicine News(10 mins):Health News:BambooIndustry.com Announces Up To 30% Discount On Its New Click Strand Woven Bamboo Floorings 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 3Health News:Promotional Bamboo Deckings from Well-known Online Supplier BambooIndustry.com 2Health News:Midtown Dentistry Announces It Is Now an Amalgam-Free Office 2Health News:Is It True That the Chiropractor Can Cause a Stroke? Dr. Harbison of AlignLife Wood River Speaks Up 2Health News:Is It True That the Chiropractor Can Cause a Stroke? Dr. Harbison of AlignLife Wood River Speaks Up 3Health News:Is It True That the Chiropractor Can Cause a Stroke? Dr. Harbison of AlignLife Wood River Speaks Up 4
... Shannon Malloy, critically injured in a car accident, skull separating ... call her recovery a miracle. ,A car ... her spine, although her skin, spinal cord and other internal ... internal decapitation, and it left her with no control over ...
... treatments. Since it is a very painful process, continuous attempts ... for the patient. ,Now researchers say that LHRH ... stop the production of a female hormone that encourages some ... action, often mimicking the action of a naturally occurring substance. ...
... and performance of other activities but as it turns out, ... ,This is the finding of a team of ... of Alberta. ,As a part study that was ... Canada, the researchers studied 24 patients, two-thirds of whom showed ...
... Moderate drinking may lower the risk of a type of ... ,The researchers at Brigham and Women's Hospital in ... of one alcoholic beverage a day were about 30 percent ... reduced risk they found in people who drank beer, wine ...
... towards making addition of folic acid to flour or bread mandatory ... disabilities. ,After lengthy public consultations the Food Standards ... its recommendations next month after it decides whether folic acid should ... ministers accept the FSA's proposals, it will be the first time ...
... a recent report, says that health specialists were able to ... the 2005 Bali bombings, thanks to improved procedures and services ... at the Royal Darwin Hospital who treated many of the ... health nurses. ,Says Anthony Guscott from Top End ...
Cached Medicine News:Health News:30-year-old Woman Survives 'internal Decapitation' 2Health News:A Fresh Alternative to Painful Chemotherapy Developed in UK 2Health News:Chronic Pain can Impair Memory and Concentration 2Health News:UK too Will Insist on Folic Acid in Bread 2Health News:UK too Will Insist on Folic Acid in Bread 3Health News:Bali Bombings Helped Improve Trauma Care 2Health News:Bali Bombings Helped Improve Trauma Care 3
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf...
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
Streck-Detergent IIIA is a balanced electrolyte solution for use as a rinsing and hemoglobin blanking diluent. It is manufactured specifically for use on the Abbott CELL-DYN® 1700 and 1800. The s...
Medicine Products: